Search

everythinglearnresearchcommunity

for

Search:↓

Many patients experience long-lasting symptoms like fatigue and pain after COVID-19, regardless of initial disease severity.

The article suggests using safety measures and telemedicine for aesthetic dermatology during COVID-19, while some procedures can still be done safely.

Skin symptoms linked to COVID-19 are hard to confirm, and more testing is needed to identify which are truly caused by the virus.

Many hospitalized children with COVID-19 had skin, mouth, or nail changes, with skin rashes being common.

Skin symptoms could help in early COVID-19 diagnosis but more research is needed to confirm their reliability.

Older adults in Vietnam often experience hair loss after COVID-19, especially women, singles, and those hospitalized.

Many healthcare workers who had Covid-19 suffer from long-term symptoms like hair loss and fatigue, especially women.

About 61% of women who had COVID-19 experienced hair loss afterward.

Using Janus kinase inhibitors (JAKi) in COVID-19 treatment requires careful consideration due to their immunosuppressive effects.

AGA might indicate higher risk for severe COVID-19.

Long-haul COVID can cause lasting symptoms affecting many body systems and may be linked to ongoing inflammation and immune system issues.

Patients treated in Respiratory Intensive Care Units for COVID-19 are more likely to get mood disorders than those in other care settings.

Many COVID-19 patients have long-term symptoms, especially women, but certain medications may help reduce these symptoms.

After severe COVID-19, 71% of patients experienced excessive hair shedding and thinning within 3 months due to factors like low oxygen levels, medication, stress, and autoimmune disease.

New treatments for COVID-19 show promise, but more effective antiviral drugs are needed.

One-third of COVID-19 patients had long-term symptoms like hair loss and fatigue, with women, older individuals, blood group B, smokers, and those with more virus exposure at higher risk.

Different ACE2 gene versions may affect COVID-19 impact based on age and suggest some hair loss drugs could be potential treatments.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Possible link between androgens and COVID-19 severity; more research needed.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

Maidenhair fern might help with COVID-19 symptoms, but it needs more testing.

Copper deficiency is linked to post-COVID-19 hair loss in women.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Men with androgenetic alopecia and hypertension may experience more severe COVID-19.

Icosapent ethyl may help treat long-lasting symptoms after COVID-19.

Spironolactone might help protect against severe lung problems in COVID-19 patients.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

University students in Egypt experienced high stress during COVID-19's third wave, with negative coping mechanisms being more common.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Blood type affects COVID-19 infection rates differently in Europe and Africa.